Clinical Laserthermia Systems AB (publ)

OM:CLS UR B Voorraadrapport

Marktkapitalisatie: SEK 22.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Beheer

Beheer criteriumcontroles 1/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Dan Mogren

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO2.6yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijnless than a year
Gemiddelde ambtstermijn bestuur3yrs

Recente managementupdates

Geen updates

Recent updates

Geen updates

Analyse CEO-vergoeding

Hoe is Dan Mogren's beloning veranderd ten opzichte van Clinical Laserthermia Systems's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022n/an/a

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensatie versus markt: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensatie versus inkomsten: Insufficient data to compare Dan's compensation with company performance.

CEO

Dan Mogren

2.6yrs

Tenure

SEK 1,551,882

Compensatie

Mr. Dan J. Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief Commer...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Dan Mogren
Chief Executive Officer2.6yrsSEK 1.55mgeen gegevens
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 1.65mgeen gegevens
Rolf Bornschein
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Jimmy Johansson
Executive Vice President of Operationsless than a yeargeen gegevensgeen gegevens
Stephan Dymling
Head of Technical Developmentno datageen gegevensgeen gegevens
Karin Peterson
Chief Product Officerno datageen gegevensgeen gegevens
Mats Ekelund
Chief Medical Officerno datageen gegevensgeen gegevens

0.8yrs

Gemiddelde duur

Ervaren management: CLS UR B's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Lars-Erik Eriksson
Co-Founder & Director17.5yrsSEK 1.65mgeen gegevens
Hans von Celsing
Independent Chairman of the Board10.5yrsSEK 285.00k0.22%
SEK 48.9k
Gunilla Savring
Independent Director3.5yrsSEK 142.50kgeen gegevens
Rolf Kiessling
Member of Clinical Advisory Board2.1yrsSEK 80.00kgeen gegevens
Karl-Göran Tranberg
Member of Clinical Advisory Board2.1yrsSEK 80.00k0.90%
SEK 200.9k
Paolo Raffaelli
Independent Director2.5yrsSEK 62.50kgeen gegevens
Marika Crohns
Independent Director & Member of Clinical Advisory Board3.5yrsSEK 142.50kgeen gegevens
Sandy Brandmeier
Independent Director2.5yrsgeen gegevensgeen gegevens

3.0yrs

Gemiddelde duur

67.5yo

Gemiddelde leeftijd

Ervaren bestuur: CLS UR B's board of directors are considered experienced (3 years average tenure).